萨拉曼卡T3-AJCC8改良版与Brigham和Tübingen高危皮肤鳞癌分期系统的性能比较
本研究在高危皮肤鳞状细胞癌(cSCC)亚组中比较了萨拉曼卡T3-AJCC8改良版、Brigham和Women's Hospital及Tübingen三种替代分期系统的性能与预后准确性。结果显示Brigham和萨拉曼卡系统在区分度、同质性和单调性上优于Tübingen系统,但三种系统的阳性预测值和准确性普遍较低,预后准确性仍不理想。
要点
- Brigham和萨拉曼卡系统比Tübingen系统更具区分度、同质性和单调性。
- Tübingen系统特异性最高,萨拉曼卡和Brigham系统敏感性更高。
- 三种系统阴性预测值均高,但阳性预测值和准确性总体较低。
核心结论
- 替代分期系统可部分克服AJCC第八版异质性和低预后准确性,使高危cSCC分层更可靠,但预后准确性仍低。
- 考虑风险因素累积可能改善高危cSCC的风险分层。
研究设计与样本
- 研究在高危皮肤鳞状细胞癌亚组中比较萨拉曼卡T3-AJCC8改良版、Brigham和Women's Hospital及Tübingen分期系统的性能和预后准确性。
- 采用同质性、单调性和McNemar检验进行成对比较,计算各分期的区分度和不良结局相对风险,并通过Akaike和贝叶斯信息准则、Harrell C指数和Gönen-Heller一致性概率估计、敏感性、特异性、阴性预测值、阳性预测值和全局准确性比较预后准确性。
主要发现
- Brigham和萨拉曼卡系统比Tübingen系统更具区分度、同质性和单调性。
- Tübingen系统特异性最高,萨拉曼卡和Brigham系统敏感性更高。
- 三种系统阴性预测值均高,但阳性预测值和准确性总体较低。
临床怎么用
- 临床可考虑使用Brigham或萨拉曼卡系统替代AJCC第八版对高危cSCC进行风险分层,但需注意其预后准确性仍有限。
- 应综合评估风险因素累积情况以改善风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The Brigham and Women's Hospital and the Tübingen cutaneous squamous cell carcinoma (SCC) stratification systems propose different criteria from the American Joint Committee on Cancer, eighth edition. Our group identified prognostic subgroups within T3 stage according to the American Joint Committee on Cancer eighth edition's classification, the most common classification for high-risk cutaneous SCCs. OBJECTIVE: To compare the performance and prognostic accuracy of these staging systems in a subset of high-risk cutaneous SCCs. METHODS: Homogeneity, monotonicity, and McNemar tests for pairwise comparisons were assessed. Distinctiveness and relative risk of poor outcome were calculated by stage. Prognostic accuracy was compared with respect to quality (Akaike and Bayesian information criteria), concordance (Harrell C-index and Gönen and Heller concordance probability estimate), and predictive accuracy (sensitivity, specificity, negative predictive value, positive predictive value, and global accuracy). RESULTS: The Brigham and Women's Hospital and Salamanca systems were more distinctive, homogeneous, and monotonic than the Tübingen system. The Tübingen system was the most specific, whereas the Salamanca and Brigham and Women's Hospital systems were more sensitive. Negative predictive value was high in all 3 systems, but positive predictive value and accuracy were low overall. CONCLUSIONS: Alternative staging systems may partially overcome the heterogeneity and low prognostic accuracy of the American Joint Committee on Cancer, eighth edition and enable high-risk cutaneous SCCs to be stratified more reliably, but their prognostic accuracy is still low. Considering the accumulation of risk factors may improve high-risk cutaneous SCC risk stratification.
引用
- Puebla-Tornero L, Corchete-Sánchez LA, Conde-Ferreirós A, et al. Performance of Salamanca refinement of the T3-AJCC8 versus the Brigham and Women's Hospital and Tübingen alternative staging systems for high-risk cutaneous squamous cell carcinoma. J Am Acad Dermatol. 2021. PMID: 33333151. doi:10.1016/j.jaad.2020.12.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。